These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 9760011)
1. The duration of antidiuretic response of two desmopressin nasal sprays. Eller N; Kollenz CJ; Bauer P; Hitzenberger G Int J Clin Pharmacol Ther; 1998 Sep; 36(9):494-500. PubMed ID: 9760011 [TBL] [Abstract][Full Text] [Related]
2. A comparative study of pharmacodynamics and bioavailability of 2 different desmopressin nasal sprays. Eller N; Kollenz CJ; Hitzenberger G Int J Clin Pharmacol Ther; 1998 Mar; 36(3):139-45. PubMed ID: 9562229 [TBL] [Abstract][Full Text] [Related]
3. Effect of food intake on the pharmacokinetics and antidiuretic activity of oral desmopressin (DDAVP) in hydrated normal subjects. Rittig S; Jensen AR; Jensen KT; Pedersen EB Clin Endocrinol (Oxf); 1998 Feb; 48(2):235-41. PubMed ID: 9579238 [TBL] [Abstract][Full Text] [Related]
4. A pharmacokinetic and pharmacodynamic comparison of desmopressin administered as whole, chewed and crushed tablets, and as an oral solution. Argenti D; Ireland D; Heald DL J Urol; 2001 May; 165(5):1446-51. PubMed ID: 11342894 [TBL] [Abstract][Full Text] [Related]
5. A pharmacokinetic and pharmacodynamic study of desmopressin: evaluating sex differences and the effect of pre-treatment with piroxicam, and further validation of an indirect response model. Odeberg JM; Callréus T; Lundin S; Roth EB; Höglund P J Pharm Pharmacol; 2004 Nov; 56(11):1389-98. PubMed ID: 15525445 [TBL] [Abstract][Full Text] [Related]
6. A replicate study design for testing bioequivalence: a case study on two desmopressin nasal spray preparations. Joukhadar C; Schenk B; Kaehler ST; Kollenz CJ; Bauer P; Müller M; Eichler HG Eur J Clin Pharmacol; 2003 Nov; 59(8-9):631-6. PubMed ID: 14564429 [TBL] [Abstract][Full Text] [Related]
7. Evidence of partial anti-enuretic response related to poor pharmacodynamic effects of desmopressin nasal spray. De Guchtenaere A; Raes A; Vande Walle C; Hoebeke P; Van Laecke E; Donckerwolcke R; Vande Walle J J Urol; 2009 Jan; 181(1):302-9; discussion 309. PubMed ID: 19013601 [TBL] [Abstract][Full Text] [Related]
8. Central diabetes insipidus in children. Antidiuretic effect and pharmacokinetics of intranasal and peroral 1-deamino-8-D-arginine vasopressin. Fjellestad-Paulsen A; Tubiana-Rufi N; Harris A; Czernichow P Acta Endocrinol (Copenh); 1987 Jul; 115(3):307-12. PubMed ID: 3618082 [TBL] [Abstract][Full Text] [Related]
9. Biologic response to subcutaneous and intranasal therapy with desmopressin in a large Amish kindred with Type 2M von Willebrand disease. Sharthkumar A; Greist A; Di Paola J; Winay J; Roberson C; Heiman M; Herbert S; Parameswaran R; Shapiro A Haemophilia; 2008 May; 14(3):539-48. PubMed ID: 18312368 [TBL] [Abstract][Full Text] [Related]
10. Effect of intranasal histamine on nasal mucosal blood flow and the antidiuretic activity of desmopressin. Olanoff LS; Titus CR; Shea MS; Gibson RE; Brooks CD J Clin Invest; 1987 Sep; 80(3):890-5. PubMed ID: 3624491 [TBL] [Abstract][Full Text] [Related]
12. Temporal delays and individual variation in antidiuretic response to desmopressin. Juul KV; Erichsen L; Robertson GL Am J Physiol Renal Physiol; 2013 Feb; 304(3):F268-78. PubMed ID: 23136002 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of high concentration intranasal and intravenous desmopressin in pediatric patients with mild hemophilia A or mild-to-moderate type 1 von Willebrand disease. Gill JC; Ottum M; Schwartz B J Pediatr; 2002 May; 140(5):595-9. PubMed ID: 12032528 [TBL] [Abstract][Full Text] [Related]
14. Intranasal and intravenous administration of desmopressin: effect on F VIII/vWF, pharmacokinetics and reproducibility. Lethagen S; Harris AS; Sjörin E; Nilsson IM Thromb Haemost; 1987 Dec; 58(4):1033-6. PubMed ID: 3127915 [TBL] [Abstract][Full Text] [Related]
15. Overnight testing of renal concentrating capacity in children using desmopressin tablets: sensitivity, repeatability and non-inferiority versus intranasal spray. Asa Rembratt ; Jens-Kristian Jensen ; Kjell Tullus ; Staffan Mårild ; Scand J Urol Nephrol; 2008; 42(3):274-7. PubMed ID: 17943639 [TBL] [Abstract][Full Text] [Related]
16. Gender difference in antidiuretic response to desmopressin. Juul KV; Klein BM; Sandström R; Erichsen L; Nørgaard JP Am J Physiol Renal Physiol; 2011 May; 300(5):F1116-22. PubMed ID: 21367921 [TBL] [Abstract][Full Text] [Related]
17. The influence of lithium on the antidiuretic effect of desmopressin. Callréus T; Holmquist IB; Lundin S; Höglund P J Pharm Pharmacol; 2002 Sep; 54(9):1279-85. PubMed ID: 12356283 [TBL] [Abstract][Full Text] [Related]
18. Gender differences in nighttime plasma arginine vasopressin and delayed compensatory urine output in the elderly population after desmopressin. Hvistendahl GM; Frøkiaer J; Nielsen S; Djurhuus JC J Urol; 2007 Dec; 178(6):2671-6. PubMed ID: 17945283 [TBL] [Abstract][Full Text] [Related]
19. Plasma pharmacokinetics of desmopressin following sublingual administration: an exploratory dose-escalation study in healthy male volunteers. Steiner IM; Kaehler ST; Sauermann R; Rinösl H; Müller M; Joukhadar C Int J Clin Pharmacol Ther; 2006 Apr; 44(4):172-9. PubMed ID: 16625986 [TBL] [Abstract][Full Text] [Related]
20. The pharmacokinetics of 400 microg of oral desmopressin in elderly patients with nocturia, and the correlation between the absorption of desmopressin and clinical effect. Hvistendahl GM; Riis A; Nørgaard JP; Djurhuus JC BJU Int; 2005 Apr; 95(6):804-9. PubMed ID: 15794787 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]